Cell Therapy News & Insights | RoslinCT

RoslinCT and Lykan Bioscience Announce the Appointment of Dr. Michael Mendicino to its Scientific Advisory Board

Leadership, Partnerships, Scientific Advisor

January 10, 2023

RoslinCT and Lykan Bioscience Announce the Appointment of Dr. Michael Mendicino to its Scientific Advisory Board

RoslinCT Boston (former Lykan Bioscience) Appoints Barbara Ressler, Ph.D. as Vice President, Manufacturing Process Sciences

Leadership

September 19, 2022

RoslinCT Boston (former Lykan Bioscience) Appoints Barbara Ressler, Ph.D. as Vice President, Manufacturing Process Sciences

RoslinCT and Lykan Bioscience Announce the Establishment of a Scientific Advisory Board

Leadership, Partnerships

September 12, 2022

RoslinCT and Lykan Bioscience Announce the Establishment of a Scientific Advisory Board

RoslinCT and Lykan Bioscience Combine to Create Leading Advanced Cell Therapy CDMO

Leadership, Partnerships

August 04, 2022

RoslinCT and Lykan Bioscience Combine to Create Leading Advanced Cell Therapy CDMO

RoslinCT Appoints Alexandra Brownfield as Head of Business Development

Leadership

July 04, 2022

RoslinCT Appoints Alexandra Brownfield as Head of Business Development

RoslinCT Appoints Lee Warren as Chief Financial Officer

Leadership

June 15, 2022

RoslinCT Appoints Lee Warren as Chief Financial Officer

RoslinCT Announces the Appointment of Peter Coleman as CEO

Leadership

May 23, 2022

RoslinCT Announces the Appointment of Peter Coleman as CEO

RoslinCT Boston (former Lykan Bioscience) Welcomes Jay Blackington as Head of People and Culture

Leadership

February 02, 2022

RoslinCT Boston (former Lykan Bioscience) Welcomes Jay Blackington as Head of People and Culture